The overexpression of ERRβ or ERRγ can inhibit the proliferation of prostate cancer cells, and some research findings indicate that the expression of ERRβ or ERRγ in prostate carcinoma is frequently diminished (Misawa and Inoue 2015). Here, ESRRB is linked to prostate cancer.